![Jill Pergande](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jill Pergande
Private Equity Investor chez
Gryphon Investors, LLC
Profil
Jill M.
Pergande is currently Managing Director at Gryphon Investors, LLC since 2022.
Former positions include Vice President at Avery Dennison Corp.
in 2018, Vice President-Human Resources at Baxter Healthcare Corp., Vice President-Human Resources at Chiron Corp., and Vice President-Human Resources at Nuvelo, Inc. from 2006 to 2009.
Education includes undergraduate and Masters of Business Administration degrees from Michigan State University.
Postes actifs de Jill Pergande
| Sociétés | Poste | Début |
|---|---|---|
Gryphon Investors, LLC
 Gryphon Investors, LLC Investment ManagersFinance Gryphon Investors invests in middle market companies located in the United States with an EBITDA of USD 80 million. The firm focuses on business services, consumer products & services, healthcare, industrial growth, information technology and software sectors. It provides financing for traditional buyouts, buy & build and growth capital requirements with an investment size ranging from USD 50 - 500 million. It takes control or shared control positions. | Private Equity Investor | 01/04/2022 |
Anciens postes connus de Jill Pergande
| Sociétés | Poste | Fin |
|---|---|---|
| AVERY DENNISON CORPORATION | Private Equity Investor | 01/03/2018 |
Nuvelo, Inc.
 Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Responsable des Ressources Humaines | 29/01/2009 |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Responsable des Ressources Humaines | - |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Responsable des Ressources Humaines | - |
Formation de Jill Pergande
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Avery Dennison Corp.
 Avery Dennison Corp. Pulp & PaperProcess Industries Designs and develops labeling and functional materials, radio frequency identification inlays, tags & software applications | Process Industries |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Health Technology |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Nuvelo, Inc.
Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Health Technology |
Michigan State University
 Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gryphon Investors, LLC
Gryphon Investors, LLC Investment ManagersFinance Gryphon Investors invests in middle market companies located in the United States with an EBITDA of USD 80 million. The firm focuses on business services, consumer products & services, healthcare, industrial growth, information technology and software sectors. It provides financing for traditional buyouts, buy & build and growth capital requirements with an investment size ranging from USD 50 - 500 million. It takes control or shared control positions. | Finance |
